0 Items
Toll Free (US) - +1-866-598-1553
sales@precisionbusinessinsights.com
Single-Photon Emission Computed Tomography Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

Single-Photon Emission Computed Tomography Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Single-Photon Emission Computed Tomography Market by Product Type (Standalone, Bi-Modal, Tri-Modal, Others ), By Applications (Medical Industry, Mechanical Industry, Others), By Distribution Channel (Hospitals, Diagnostic imaging centers, Ambulatory surgical centers), and Geography

 

Request Sample Request Methodology
Request Sample Read More
$ PRICE - $ 3,000.00 – $ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00 – $ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,
Report

Description

Single-Photon Emission Computed Tomography Market size was valued at USD 2.55 billion in 2021 and is expected to grow at a CAGR of 6.8% from 2022 to 2028. This report studies global single-photon emission computed tomography market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. A Single Photon Emission Computed Tomography (SPECT) scan is a medical imaging technique that shows how blood flows to tissues and organs. A single photon emission computed tomography (SPECT) scan integrates two technologies which consists of computed tomography (CT) and a radioactive material (tracer).  The tracer allows the doctors to see how blood flows to tissues and organs. A radioactive-labeled pharmaceutical (radiopharmaceutical) is administered to a patient. The chemical that is radiolabeled, meaning it emits gamma rays that can be detected by the scanner. The computer collects the information emitted by the gamma rays and translates them into two-dimensional cross-sections. These cross-sections can be added back together to form a 3D image of your brain.

Key Developments:

In October 2017, Siemens Healthineers unveils new software features designed to bring advanced clinical capabilities to the Biograph Vision as well as the company’s established Biograph mCT and Biograph mCT Flow PET/CT systems

Single-Photon Emission Computed Tomography Market

MARKET SUMMARY
-
6.8%
  • Study Period– 2023 – 2029
  • Base Year– 2022
  • CAGR– 6.8%
  • Largest Market– North America
  • Fastest Market- Asia-Pacific
Single-Photon Emission

Computed Tomography Market Analysis

  • Single-Photon Emission Computed Tomography Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa.
  • The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type (standalone, bi-modal, tri-modal, others ), by application (medical industry, mechanical industry, others), by distribution channel (hospitals, diagnostic imaging centers, ambulatory surgical centers) and regions.
Market Leaders
  • Philips (The Netherlands)
  • Siemens (Germany)
  • Positron Corporation (U.S)
  • Gamma Medica Inc. (U.S)
  • GE Healthcare (U.K)
  • Hologic Inc. (U.S)
  • Bruker Corporation (U.S)
Single-Photon Emission Computed Tomography Market

Drivers and Restraints

Increase in the prevalence of chronic disorders, adoption of advanced treatment options, rising disease awareness levels among the patients, growing geriatric population, are expected to drive the growth of single-photon emission computed tomography market. However, some of the reasons such as huge capital investments, shorter half-life of radioisotopes and reimbursement issues are expected to hamper the growth of the single photon emission computed tomography (SPECT) market. Product recalls is another factor that is creating a negative impact on the worldwide market for SPECT which is facing challenges in terms of revenue growth.

Single-Photon Emission Computed Tomography Market Regional Analysis

North America dominates the market

North America single photon emission computed tomography (SPECT) market is expected to dominate the revenue share due to high adoption of advanced technologies and increase in the prevalence of chronic disorders. High adoption of cutting-edge technologies, sophisticated healthcare infrastructure are expected to create demand for SPECT market in this region. However, Asia-Pacific single photon emission computed tomography (SPECT) market is expected to grow further due to developing infrastructure in case of research, increasing patient pool, and increasing awareness about the chronic disorders among the patients.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis
Single-Photon Emission Computed Tomography Market Segmentation

segmentation-block-image

Product Type

    • Standalone
    • Bi-Modal
    • Tri-Modal
    • Others
segmentation-block-image

Application

    • Cardiology
    • Neurology
    • Others
segmentation-block-image

Distribution Channel

    • Hospitals
    • Diagnostic imaging centers
    • Ambulatory surgical centers
segmentation-block-image

Geography

    • North America
    • Europe,
    • Asia Pacific
    • Latin America
    • Middle East and Africa
Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Report

Table Of Content

Request Table of Content

Report

Company Profile

  • Philips (The Netherlands)
  • Siemens (Germany)
  • Positron Corporation (U.S)
  • Gamma Medica Inc. (U.S)
  • GE Healthcare (U.K)
  • Hologic Inc. (U.S)
  • Bruker Corporation (U.S)
  • Mediso Ltd., (Hungary)
  • Digirad Corporation
  • CardiArc Ltd. (U.S)
  • Agfa-Gevaert N.V. (Belgium)

Description

Single-Photon Emission Computed Tomography Market size was valued at USD 2.55 billion in 2021 and is expected to grow at a CAGR of 6.8% from 2022 to 2028. This report studies global single-photon emission computed tomography market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. A Single Photon Emission Computed Tomography (SPECT) scan is a medical imaging technique that shows how blood flows to tissues and organs. A single photon emission computed tomography (SPECT) scan integrates two technologies which consists of computed tomography (CT) and a radioactive material (tracer).  The tracer allows the doctors to see how blood flows to tissues and organs. A radioactive-labeled pharmaceutical (radiopharmaceutical) is administered to a patient. The chemical that is radiolabeled, meaning it emits gamma rays that can be detected by the scanner. The computer collects the information emitted by the gamma rays and translates them into two-dimensional cross-sections. These cross-sections can be added back together to form a 3D image of your brain.

Key Developments:

In October 2017, Siemens Healthineers unveils new software features designed to bring advanced clinical capabilities to the Biograph Vision as well as the company’s established Biograph mCT and Biograph mCT Flow PET/CT systems

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX

QUICKLINKS
RESEARCH AREAS
PRESS RELEASE
CONTACT US
+1-866-598-1553
EMAIL
sales@precisionbusinessinsights.com
FOLLOW US
QUICK LINKS+
RESEARCH AREAS+
PRESS RELEASE+
CONTACT US+
+1-866-598-1553
sales@precisionbusinessinsights.com
FOLLOW US AT+